Clinical Trial

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2024 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 3, randomized, double-Masked, vehicle-controlled, multi-center study designed to evaluate the safety and efficacy of 5% VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-06.
Status change: Not Yet Recruiting → Recruiting 2024-11-17
Trial Details
NCT Number NCT06360133
Lead Sponsor VivaVision Biotech, Inc
Conditions Dry Eye
Enrollment 700 participants
Start Date 2024-04-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-20